Natriuretic peptides and cGMP signaling control of energy homeostasis.
about
Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?Increased Hydration Can Be Associated with Weight LossNatriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsNatriuretic Peptides and Cardiometabolic HealthMicroRNA Functions in Brite/Brown Fat - Novel Perspectives towards Anti-Obesity StrategiesThe effect of age and NT-proBNP on the association of central obesity with 6-years cardiovascular mortality of middle-aged and elderly diabetic people: the population-based Casale Monferrato study.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Sibjotang Increases Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.Optical control of a receptor-linked guanylyl cyclase using a photoswitchable peptidic hormone.Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.Gene expression in a rarely studied intraabdominal adipose depot, the round ligament, in severely obese women: A pilot study.Does continuous endurance exercise in water elicit a higher release of ANP and BNP and a higher plasma concentration of FFAs in pre-obese and obese men than high intensity intermittent endurance exercise? - study protocol for a randomized controlledA heart-adipose tissue connection in the regulation of energy metabolism.Endogenous ways to stimulate brown adipose tissue in humans.Regulation of adipocyte lipolysis.Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans.Privileged frameworks from snake venom.Targeting fatty acid metabolism to improve glucose metabolism.Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.Factors involved in white-to-brown adipose tissue conversion and in thermogenesis: a review.Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolismNTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato StudyImpaired atrial natriuretic peptide-mediated lipolysis in obesity.Circulating N-terminal brain natriuretic peptide and cardiac function in response to acute systemic hypoxia in healthy humans.FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.[Control of energy metabolism by natriuretic peptides].Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.
P2860
Q26741084-55ED947D-25E4-4831-B655-A536CC209472Q26744779-5A9EB506-5F21-4542-AEB1-9C099BAAA156Q26778333-C40D6E6E-2714-4457-89B6-EB7E99571BCFQ26827702-3B15808C-0E6F-41C7-9803-A3EE8C0CF6C1Q26830503-CA192A15-4699-4B76-93C5-774BDEDD5B41Q33553698-B7D4D082-A606-4D35-8C9D-C07F9185BF49Q35042217-F79B338B-1B1D-4D28-8766-3CE5274B1C2AQ36162689-67A3E283-CC33-4937-B7BA-BBB93BF33B02Q36199888-75C0CBA7-7FBF-4A27-BAF7-35C647D4DE86Q36408637-BDC03060-2CF8-4037-AB12-3692FCFBF02CQ36709153-4889F56A-111E-43E5-A9C5-C6C606ECFACFQ36812425-E3F49ACE-F811-4359-AC33-E88521651B02Q37365813-29D4D773-42B7-4B94-97E9-7CA85D7CC536Q38168030-FFF4FB58-96BD-42BE-AF2E-2B805FF14AABQ38187493-71784C62-6915-49B8-A25A-2FF882797252Q38215702-F498CDF6-FED4-437E-8E79-A8E7D4BB390AQ38217888-EEC44AD7-15FF-4DCF-981B-5381310D77B6Q38360688-F3284ECC-55A6-4E00-BE80-BAAC78118E05Q38548027-C518A724-24AA-4AEA-A0F0-B1D9927BD989Q38931035-46D7AE8E-8483-4226-9443-88D614FAFD66Q38992403-403EC68A-B524-4607-AD81-1AC1C1A95970Q39130400-D5599B62-0D35-4B32-A895-9F7562383ED5Q42010491-5F8755CD-A555-45C2-B1DA-EA517D694457Q42363898-810E1280-539A-4083-9938-CF19A9BAD93CQ42484201-3114CB90-33E4-4A5F-9F41-4B7DC97B2724Q42724785-758B97B6-DDA4-498B-A27F-B4939ED28041Q42832081-52964842-DD18-4927-ABCB-ECA2143D7FB0Q43565469-3B4351A8-6090-4CAC-9E55-3563FC215DC2Q48215808-88E49D44-7578-41F1-853B-51F603A41FFAQ48465860-5F90C67A-5BDB-4C07-BA0E-81D8854B33E7Q50122007-67032163-D567-44D3-942F-9D7A127BEF75
P2860
Natriuretic peptides and cGMP signaling control of energy homeostasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Natriuretic peptides and cGMP signaling control of energy homeostasis.
@en
type
label
Natriuretic peptides and cGMP signaling control of energy homeostasis.
@en
prefLabel
Natriuretic peptides and cGMP signaling control of energy homeostasis.
@en
P2860
P1476
Natriuretic peptides and cGMP signaling control of energy homeostasis
@en
P2093
Max Lafontan
P2860
P304
P356
10.1152/AJPHEART.00704.2012
P50
P577
2012-11-30T00:00:00Z